Search research articles
Contact Us
Filters
Showing results (71-80 of 249) with videos related to
Page
of 25
Sort By:
American Heart Journal
|
December 12, 2017
Effect of high-dose oral multivitamins and minerals in participants not treated with statins in the randomized Trial to Assess Chelation Therapy (TACT)
Omar M Issa, Rhonda Roberts, Daniel B Mark, et al.
European Heart Journal. Acute Cardiovascular Care
|
April 28, 2025
The intersection of obesity and acute heart failure: Cardiac structure and function and congestion across BMI categories
Sofie Bøgh-Sørensen, Ross T Campbell, Brian L Claggett, et al.
Journal of Cardiac Failure
|
March 25, 2018
Incident Hyperkalemia, Hypokalemia, and Clinical Outcomes During Spironolactone Treatment of Heart Failure With Preserved Ejection Fraction: Analysis of the TOPCAT Trial
Akshay S Desai, Jiankang Liu, Marc A Pfeffer, et al.
Journal of Cardiac Failure
|
February 28, 2006
Characteristics of patients who die with heart failure and a low ejection fraction in the new millennium
Jeffrey J Teuteberg, Eldrin F Lewis, Anju Nohria, et al.
Annals of Internal Medicine
|
February 4, 2014
Oral high-dose multivitamins and minerals after myocardial infarction: a randomized trial
Gervasio A Lamas, Robin Boineau, Christine Goertz, et al.
American Heart Journal
|
June 20, 2017
Impact of continuous positive airway pressure and oxygen on health status in patients with coronary heart disease, cardiovascular risk factors, and obstructive sleep apnea: A Heart Biomarker Evaluation in Apnea Treatment (HEARTBEAT) analysis
Eldrin F Lewis, Rui Wang, Naresh Punjabi, et al.
The New England Journal of Medicine
|
April 27, 2017
Spironolactone Metabolites in TOPCAT - New Insights into Regional Variation
Simon de Denus, Eileen O'Meara, Akshay S Desai, et al.
European Journal of Heart Failure
|
May 23, 2026
Cardiovascular events after acute myocardial infarction complicated by low ejection fraction and/or congestion: a landmark analysis of the PARADISE-MI trial
Jacinthe Boulet, Jean-Lucien Rouleau, Mark Petrie, et al.
Circulation
|
June 23, 2017
Physical Activity and Prognosis in the TOPCAT Trial (Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist)
Sheila M Hegde, Brian Claggett, Amil M Shah, et al.
JACC. Heart Failure
|
September 13, 2020
Associations Between Depressive Symptoms and HFpEF-Related Outcomes
Alvin Chandra, Michael A D Alcala, Brian Claggett, et al.
Page
of 25
Search research articles
Search
Showing results (71-80 of 249) with videos related to
Sort By:
Page
of 25
American Heart Journal
|
December 12, 2017
Effect of high-dose oral multivitamins and minerals in participants not treated with statins in the randomized Trial to Assess Chelation Therapy (TACT)
Omar M Issa, Rhonda Roberts, Daniel B Mark, et al.
European Heart Journal. Acute Cardiovascular Care
|
April 28, 2025
The intersection of obesity and acute heart failure: Cardiac structure and function and congestion across BMI categories
Sofie Bøgh-Sørensen, Ross T Campbell, Brian L Claggett, et al.
Journal of Cardiac Failure
|
March 25, 2018
Incident Hyperkalemia, Hypokalemia, and Clinical Outcomes During Spironolactone Treatment of Heart Failure With Preserved Ejection Fraction: Analysis of the TOPCAT Trial
Akshay S Desai, Jiankang Liu, Marc A Pfeffer, et al.
Journal of Cardiac Failure
|
February 28, 2006
Characteristics of patients who die with heart failure and a low ejection fraction in the new millennium
Jeffrey J Teuteberg, Eldrin F Lewis, Anju Nohria, et al.
Annals of Internal Medicine
|
February 4, 2014
Oral high-dose multivitamins and minerals after myocardial infarction: a randomized trial
Gervasio A Lamas, Robin Boineau, Christine Goertz, et al.
American Heart Journal
|
June 20, 2017
Impact of continuous positive airway pressure and oxygen on health status in patients with coronary heart disease, cardiovascular risk factors, and obstructive sleep apnea: A Heart Biomarker Evaluation in Apnea Treatment (HEARTBEAT) analysis
Eldrin F Lewis, Rui Wang, Naresh Punjabi, et al.
The New England Journal of Medicine
|
April 27, 2017
Spironolactone Metabolites in TOPCAT - New Insights into Regional Variation
Simon de Denus, Eileen O'Meara, Akshay S Desai, et al.
European Journal of Heart Failure
|
May 23, 2026
Cardiovascular events after acute myocardial infarction complicated by low ejection fraction and/or congestion: a landmark analysis of the PARADISE-MI trial
Jacinthe Boulet, Jean-Lucien Rouleau, Mark Petrie, et al.
Circulation
|
June 23, 2017
Physical Activity and Prognosis in the TOPCAT Trial (Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist)
Sheila M Hegde, Brian Claggett, Amil M Shah, et al.
JACC. Heart Failure
|
September 13, 2020
Associations Between Depressive Symptoms and HFpEF-Related Outcomes
Alvin Chandra, Michael A D Alcala, Brian Claggett, et al.
Page
of 25